Background

Improving haemophilia care and treatment in the developing world

The Novo Nordisk Haemophilia Foundation (NNHF) was created in 2005 to address the significant need for improving haemophilia care in the developing world where haemophilia is currently not a healthcare priority and still today many haemophilia patients go undiagnosed or are inadequately treated.

NNHF is an independent non-profit entity, located in Zurich, Switzerland, and funds programmes to improve haemophilia care, treatment and awareness in the developing world.

NNHF programmes include for instance awards, fellowships and projects for patient education, doctor, nurse and laboratory staff training, as well as setting up diagnostic facilities and patient registries.